Luc Berghman
23Patents
7h-index
18Co-inventors
62Inventor score
Filing activity: Sep 18, 2007 → May 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8604178B2 | Compositions and methods of enhancing immune responses | Emerging Cross-Sectional Technologies | 31 | Active |
| US9125854B2 | Compositions and methods of enhancing immune responses to flagellated bacterium | Emerging Cross-Sectional Technologies | 18 | Active |
| US8956849B2 | Compositions and methods of enhancing immune responses to Eimeria | Emerging Cross-Sectional Technologies | 18 | Active |
| US9226957B2 | Compositions and methods of enhancing immune responses | Emerging Cross-Sectional Technologies | 16 | Active |
| US8956618B2 | Vaccine vectors and methods of enhancing immune responses | Emerging Cross-Sectional Technologies | 15 | Active |
| US9913893B2 | Vaccine vectors and methods of enhancing immune responses | Emerging Cross-Sectional Technologies | 10 | Active |
| US9603915B2 | Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection | Emerging Cross-Sectional Technologies | 9 | Active |
| US10004798B2 | Compositions and methods of enhancing immune responses | Emerging Cross-Sectional Technologies | 7 | Active |
| US10016493B2 | Compositions and methods of enhancing immune responses to Eimeria | Emerging Cross-Sectional Technologies | 6 | Active |
| US9884099B2 | Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection | Emerging Cross-Sectional Technologies | 5 | Active |
| US10407491B2 | Mosaic chimeric viral vaccine particle | Chemistry; Metallurgy | 3 | Active |
| US10328137B2 | Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection | Emerging Cross-Sectional Technologies | 3 | Active |
| US10716840B2 | Compositions and methods of enhancing immune responses to enteric pathogens | Emerging Cross-Sectional Technologies | 1 | Active |
| US10376571B2 | Compositions and methods of enhancing immune responses to enteric pathogens | Emerging Cross-Sectional Technologies | 1 | Active |
| US10836809B2 | Mosaic chimeric viral vaccine particle | Chemistry; Metallurgy | 1 | Active |
| US11013792B2 | Compositions and methods of enhancing immune responses to enteric pathogens | Emerging Cross-Sectional Technologies | 0 | Active |
| US11904005B2 | Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US10842858B2 | Compositions and methods of enhancing immune responses to Eimeria | Emerging Cross-Sectional Technologies | 0 | Active |
| US11382962B2 | Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same | Emerging Cross-Sectional Technologies | 0 | Active |
| US10792351B2 | Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US11364290B2 | Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US10682398B2 | Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same | Emerging Cross-Sectional Technologies | 0 | Active |
| US11352416B2 | Mosaic chimeric viral vaccine particle | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.